Check Credit Score
Check Credit Score
HomeNewsIndia

Toyota Kirloskar Motor to resume manufacturing operations from May 26

The company officials are closely monitoring and evaluating the situation to gradually ramp up operations, the company added.

May 25, 2020 / 06:26 PM IST

Toyota Kirloskar Motor (TKM) on Monday said it will resume its manufacturing operations at its Bidadi (Karnataka) plant from Tuesday.

After weeks of lockdown and partial lifting of restrictions across the country, the company will re-start production at the facility from May 26 in a phased manner, in concurrence with the directives of both, the state and the central governments, TKM said in a statement.

The company officials are closely monitoring and evaluating the situation to gradually ramp up operations, it added.

More than 290 dealerships of the company and 230 service outlets have also resumed operations across the country, the automaker said.

"While restarting operations, we have deliberately been very circumspect to take some more time owing to the fact that we wanted to take extra precautions so as to ensure that both the workplace and its surrounding are safe for us to resume work," TKM Deputy Managing Director Raju B Ketkale said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The physical and mental well-being of employees is of utmost importance to the company and it does not want to jeopardise the same at any cost, he added.

The company said it had introduced a set of safety initiatives at its plant as well as dealerships.

PTI
first published: May 25, 2020 06:10 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347